parkinson's treatment with hyperbaric chamber and glutathione Frontiers Hyperbaric Medical Solutions Offers IV
Description
Funding This research was funded by Innovation Team Project of Dalian Ocean University, China (B202102) and the Central Guidance on Local Science and Technology Development Fund of Hebei Province (226Z7103G), China
J.WickremesekeraA.PengL.GrayC
Patients treated for osteoporosis In addition to a negative effect on bone mineralisation, patients taking potent antiresorptive therapy are at risk of severe hypocalcaemia when these are used in the presence of vitamin D deficiency
Vona, R., Pallotta, L., Cappelletti, M., Severi, C
doi: 10.1089/ars.2011.4391 [DOI] [PMC free article] [PubMed] [Google Scholar] 52.Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC
Setria : registered trademark of Kyowa Hakko Bio Co.., Ltd
